Arm Near IPO Price After Dramatic Debut

It's early days but the hype has evaporated quickly after a big first day as a public company

James Gard 22 September, 2023 | 12:06AM
Facebook Twitter LinkedIn

Arm holdings

A week after Arm (ARM) floated in New York, how’s life as a public company going for the UK-based chip designer?

As often happens when shares “pop” on the first day, the hangover often follows pretty quickly after the party. Arm shares surged nearly 25% last Thursday, but this week they’ve traded below their IPO price of $51. Last night’s close saw the shares at $52.16, making the company worth $53.53 billion (£43 billion). As my back story shows, SoftBank bought Arm for $32 billion, or £24 billion at 2016 exchange rates.

ARM share price

As my colleague Jocelyn Jovene pointed out last week, the stock trades on an earnings per share multiple of 86 times earnings for fiscal 2023 and 66 times for 2024 – making it one of the most expensive stocks in the semiconductor industry. Ahead of the float on September 14, Morningstar analyst Javier Correonero said that “from a valuation point of view,” says, an equity analyst at Morningstar, the stock looks “very, very expensive.” That was based on a valuation of $50 billion, and at one point last week that surged to $60 billion.

Still, it’s very early days and we await Morningstar coverage on the stock. The track record for highly priced IPOs is mixed at best. Uber is still trailing its 2019 float price, but Facebook, now Meta has increased in value almost 700% since it made itde debut in 2012. Hype is generally bad for new investors in the short term, but it’s hard to predict whether a company has the staying power to go on from a blockbuster debut.

For More Equity Analysis

Sign up to our newsletters

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

James Gard

James Gard  is senior editor for Morningstar.co.uk

 

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures